XXXXXXXX KOMISE (XX) 2021/383
xx dne 3.&xxxx;xxxxxx 2021,
xxxxxx xx xxxx xxxxxxx XXX xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) č. 1107/2009 uvedením xxxxxxx xxxxxxxxxxxx xxxxxx, xxxxx xxxx xxxxxxxxxxxx xxxx xxxxxxx xxxxxxxxx xx ochranu xxxxxxx
(Xxxx x&xxxx;xxxxxxxx xxx XXX)
XXXXXXXX XXXXXX,
x&xxxx;xxxxxxx xx Xxxxxxx x&xxxx;xxxxxxxxx Xxxxxxxx xxxx,
x&xxxx;xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (ES) x.&xxxx;1107/2009 ze dne 21.&xxxx;xxxxx&xxxx;2009 x&xxxx;xxxxxxx xxxxxxxxx xx xxxxxxx xxxxxxx xx xxx x&xxxx;x&xxxx;xxxxxxx xxxxxxx Xxxx 79/117/XXX x&xxxx;91/414/XXX&xxxx;(1), a zejména na xx.&xxxx;27 odst. 2 x&xxxx;xx.&xxxx;78 xxxx.&xxxx;2 xxxxxxxxx xxxxxxxx
xxxxxxxx x&xxxx;xxxxx xxxxxxx:
(1) |
Xxxxxxxxxx přísady xxxx xxxxxxx x&xxxx;xx.&xxxx;2 xxxx.&xxxx;3 xxxx. c) xxxxxxxx (ES) x.&xxxx;1107/2009&xxxx;xxxx xxxxx xx přípravky, xxxxx xx xxxxxxxxx x&xxxx;xxxxxxxxxxx xx xxxxxxx xxxxxxx xx v adjuvantech xxxx xxxx x&xxxx;xxxxxxxx xxxxxxx xxxxxx, avšak xxxxx xxxxxxx xxxx xxxxxx látky, xxxxxxxx xxx synergenty. |
(2) |
Formulační přísady xxxx xxxxxxxxxxxx jako xxxxxxx přípravků xx xxxxxxx xxxxxxx, xxxxx xxxxxx rezidua, která xxxxxxx po xxxxxxxx x&xxxx;xxxxxxx xx xxxxxxxx xxxxx x&xxxx;xxxxxxx xxxxxxx xxx zohlednění skutečných xxxxxxxx použití, xxxx xxxxxxxx účinky xx xxxxxx lidí xxxx xxxxxx xxxxx xx xxxxxxxx xxxx či xxxxxxxxxxxx účinky na xxxxxxx xxxxxxxxx. Xxxxxxxxxx xxxxxxx xxxx rovněž xxxxxxxxxxxx xxxx xxxxxxx xxxxxxxxx na ochranu xxxxxxx, xxxxx xxxxxx xxxxxxxxx po xxxxxxxx x&xxxx;xxxxxxx xx xxxxxxxx xxxxx x&xxxx;xxxxxxx rostlin xxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxx xx xxxxxxxx xxxxxx xx xxxxxx xxxx nebo xxxxxx xxxxx nepřijatelné xxxxxx xx rostliny, xxxxxxxxx xxxxxxxx nebo xxxxxxx xxxxxxxxx. Xxxxxx xxxxxxxxxxxx xxxxxxxxxx přísady xxxx xxx xxxxxxx xx seznamu v příloze XXX xxxxxxxx (ES) x.&xxxx;1107/2009. |
(3) |
Xxxxxxxxxx xxxxxxx jsou xxxxx nebo xxxxxxxxx xxxxxxxxx xxxxxxxx s účinnými xxxxxxx v přípravcích xx xxxxxxx xxxxxxx, x&xxxx;xxxx xxxxx rovněž šířeny x&xxxx;xxxxxxxx xxxxxxxxx. Proto xx xxxxxxxx xxxxxxxx xx xxxxxxxx zdraví, xxxxxxxxx prostředí, xxxxxxxxxxx x&xxxx;xxxxxxxxxx xxx xxxxxxxxx x&xxxx;xxxxxx 3.6.2, 3.6.3, 3.6.4, 3.6.5, 3.7, 3.8.2 x&xxxx;3.10 xxxxxxx XX xxxxxxxx (ES) x.&xxxx;1107/2009 xxxx být xxxxxx xxxxxxxxxx xxx xxxxxxxxxxxx nepřijatelných xxxxxxxxxxxx xxxxxx. |
(4) |
Xxxxxx xxxxxxxxxxxxxx formulačních xxxxxx by měl xxxxx zahrnovat látky x&xxxx;xxxxxxxxxxxxxx xxxxxxxxxxx xxxx xxxxxxxxxxx, xxxxxxxxx 1 A nebo 1X, xxxx mutageny, xxxxxxxxx 1&xxxx;X&xxxx;xxxx 1X, xxxx xxxx xxxxxxx xxx xxxxxxxxxx, xxxxxxxxx 1&xxxx;X&xxxx;xxxx 1B, x&xxxx;xxxxxxx x&xxxx;xxxxxxxx XX xxxxxxxx Xxxxxxxxxx parlamentu a Rady (XX) x.&xxxx;1272/2008&xxxx;(2). |
(5) |
Xxxxxx nepřijatelných xxxxxxxxxxxx xxxxxx by xxx dále xxxxxxxxx xxxxx xxxxxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxxxxxxxxxxx a toxické („XXX“) xxxx xxxxxx xxxxxxxxxxxx a vysoce xxxxxxxxxxxxxxx („xXxX“) x&xxxx;xxxxxxx x&xxxx;xx.&xxxx;57 xxxx. x) x&xxxx;x) xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (ES) x.&xxxx;1907/2006&xxxx;(3). |
(6) |
Xxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx xxxxxx xx xxx xxxxxx xxxxxxxxx xxxxx xxxxxxxxxx xxxxxxxxx obavy v důsledku xxxxxxxxxx vyvolávajících narušení xxxxxxxxxx xxxxxxxx v souladu x&xxxx;xx.&xxxx;57 xxxx. x) xxxxxxxx (XX) x.&xxxx;1907/2006 xxxx xxxxx xxxxxxxxxxxxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxx nařízení Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;528/2012&xxxx;(4) xxxx xxxxx xxxxxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxxxxx xxxxxxxxxxxx xxxxx („XXX“) xxxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) 2019/1021&xxxx;(5). |
(7) |
Xxxxxxxx (ES) x.&xxxx;1907/2006 xxxxxxx x&xxxx;xxxxxxx XXXX xxxxxxx xxx xxxxxxx xxxxxxxxxx látky. Xxxxxxx-xx použití uvedených xxxxx xxxxxxx xxxxxxxxxxxx xxxxxx x&xxxx;xxxxxxxxxxx na xxxxxxx xxxxxxx xxxxxxxx, xxxx xx xxx xxxxxxxx xx seznam xxxxxxxxxxxx xxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (ES) x.&xxxx;1107/2009. |
(8) |
Xxxxxxx státy xxxxxxxxxxxxxx xxxxxxxxxx xxxxxxx, xxxxx xxxxxxxx xx xxxxxxxxxxxx x&xxxx;xxxxxxxxxxx na xxxxxxx xxxxxxx povolených xxxxx xxxxxxxx Xxxx 91/414/EHS (6) xxxx xxxxxxxx (XX) x.&xxxx;1107/2009. Xxxxxx xxxxxxxxxx xxxxxxx oznámily Xxxxxxxx, Xxxxxx, Francie, Xxxxxxx, Xxxxxx, Litva, Xxxxxxxxx x&xxxx;Xxxxxx. X&xxxx;xxxxxxxxx formulačních xxxxxx xx xxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxxxxx xxxx xxxxxxxxxxx, kategorie 1&xxxx;X&xxxx;xxxx 1X, jako xxxxxxxx, xxxxxxxxx 1&xxxx;X&xxxx;xxxx 1X, xxxx xxxx xxxxxxx xxx xxxxxxxxxx, xxxxxxxxx 1&xxxx;X&xxxx;xxxx 1X, v souladu x&xxxx;xxxxxxxx XX nařízení (XX) x.&xxxx;1272/2008, přísady xxxxxxxxxxxxxx xxxx XXX xxxx vPvB xxxxx xx.&xxxx;57 písm. x) x&xxxx;x) nařízení (XX) x.&xxxx;1907/2006, přísady xxxxxxxxxxxxxx xxxx xxxxx xxxxxxxxxx xxxxxxxxx xxxxx x&xxxx;xxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxx x&xxxx;xx.&xxxx;57 xxxx. x) xxxxxxxx (XX) x.&xxxx;1907/2006 x&xxxx;xxxxxxx xxxxxxxxxxxxxx xxxx XXX xxxxx nařízení (XX) 2019/1021 měly xxx uvedeny na xxxxxxx x&xxxx;xxxxxxx III xxxxxxxx (XX) x.&xxxx;1107/2009. |
(9) |
Xxxxxxx xxxxxxxxxxxxxx xxxxx xxxx (x.&xxxx;XXX 61791-26-2) x&xxxx;xxxxxxxxxxx xx xxxxxxx xxxxxxx xxxxxxxxxxxx glyfosát xxxx xxxxxxxx xxxxxxxxxx xxxxxxxxx Xxxxxx (EU) 2016/1313&xxxx;(7), xxxxxxx xxxx xxxxxxxx xxxxx x&xxxx;xxxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxxx xxxxx xxxx x&xxxx;xxxxxx xxxxxxxxxxx mít xxxxxxxxx vliv na xxxxxx xxxxxx. Xxxxxxxx x&xxxx;xxxx, xx uvedené xxxxx vyplývají x&xxxx;xxxxxxxxxxx xxxxxxxxxx xxxxxxxxx xxxxx, x&xxxx;xx proto xxxxxx xxxxxxx xx xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx glyfosát, xxx mají stejnou xxxxxxxx pro xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxx xxxxx, měly xx xxx ethoxylované xxxxx xxxx rovněž xxxxxxxx xx seznam xxxxxxxxxxxx xxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (ES) x.&xxxx;1107/2009. |
(10) |
Xxxxxxxxxxx xxxxxxxxxxxx Xxxxxx (XX) 2016/109 (8) x&xxxx;(XX) 2018/619&xxxx;(9) xxxxxx schváleny xxxxx XXXX (1600; 1.8), xxxxx XXX 27083-27-8 x&xxxx;32289-58-0, x&xxxx;XXXX (1415; 4.7), xxxxx XXX 32289-58-0 x&xxxx;1802181-67-4, xxxx stávající účinné xxxxx xxx xxxxxxx x&xxxx;xxxxxxxxxx xxxxxxxxxxx typu 6 (xxxxxxxxxxx pro xxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx), xxxx jinými xxxx xxxxxxxxx x&xxxx;xxxxxxxx nepřijatelných xxxxx xxx xxxxxx xxxxxx a životní xxxxxxxxx. Xxxxxx xxxxxxx xxxx xxxxxxxxxxx xxx xxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxxx xx xxxxxxx rostlin xx proto xxxxx x&xxxx;xxxxxxxxxxxxx xxxxxxx na xxxxxx zdraví a životní xxxxxxxxx. Proto by xxxxx XXXX (1600; 1.8) a PHMB (1415; 4.7) xxxx xxx xxxxxx xxxxxxx xx xxxxxxx v příloze III xxxxxxxx (XX) x.&xxxx;1107/2009. |
(11) |
Xxxxxxxxxx xxxxxxx, xxxxx xxxx xxx xxxxxxx xx xxxxxxx v příloze XXX xxxxxxxx (XX) x.&xxxx;1107/2009 xxxxx xxx xxxxxx xxxxxxxx x&xxxx;xxxxxxxxxxx xxxxxxxxx xx xxx. Xxxxxxx xxxxx xxxxxx xxxxxxxxx xxxxxxxx pravidla xxx xxxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxx x&xxxx;xx.&xxxx;58 xxxx.&xxxx;2 xxxxxxxx (XX) č. 1107/2009, xxxxx xxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxxxxxx předpisy xxxxxxxx xx adjuvantů, xxxxx xxxx x&xxxx;xxxxxxx x&xxxx;xx.&xxxx;81 odst. 3 xxxxxxxxx xxxxxxxx. Xxxxxxx nařízení (XX) č. 1107/2009 xx xx xxx xxxxxxxx xxxxxxx na trh xxxx používání xxxxxxxxx xxxxxxxxxxxx xxxxxxxx formulační xxxxxxx, je xxxxxxx xxxxxxxx, xxx xxxxxx xxxxxxxxx, které xxxx xxx smíseny x&xxxx;xxxxxxxxx xx xxxxxxx rostlin, xxxxxxxxxxxx xxxxx z uvedených xxxxxxxxxxxxxx xxxxxxxxxxxx xxxxxx. |
(12) |
Xxxxxxxx xxxxxx xx xxx xxx poskytnut dostatek xxxx xx xxxxxxx xxxxxxx xxxxxxxxx xx xxxxxxx xxxxxxx x&xxxx;xxxxxxxxx, xxxxx xxxx v současnosti xxxxxxxx na jejich xxxxx, aby mohly xxxxxxxx, zda xxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxx xx xxxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (ES) x.&xxxx;1107/2009, x&xxxx;xxx xxxxx xxxxxxxx xxxx xxxxxx xxxxxxxx přípravků xx xxxxxxx xxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxxxx. |
(13) |
X&xxxx;xxxxxxxxx na xxxxxxx xxxxxxx xxxx adjuvantů xxxxxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxx xx xxxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (XX) x.&xxxx;1107/2009, pro xxx xxxxxxx xxxxx xxxxx xxxxxxxxxx odkladnou xxxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;46 xxxxxxxxx xxxxxxxx xxxx xxxxxxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx pro xxxxxxxxxx xxxxxxxxx, by xxxxxxx xxxxx xxxx xxxxxxxx xxx xxxxxx x&xxxx;xxxxxxxxxx xxxxxxxxxx xx xxx xxxxxx x&xxxx;xxx xxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxx za xxxxxxx devět měsíců xx xxxx xxxxx xxxx xxxxxx xxxxxxxx. |
(14) |
Xxxxxxxxxx xxxxxxx, xxxxx xxxx xxx xxxxxxx xx xxxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (ES) č. 1107/2009, xxxxx být přítomny xxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxx formulačních xxxxxxxxx, xxxxx xxxx xxxx xxxxxx přijatelné pro xxxxxxx x&xxxx;xxxxxxxxxxx xx xxxxxxx xxxxxxx nebo xxxxxxxxxxx. Xxxxx xx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx xxxxxx x&xxxx;xxxxxxxx xxxxxxxxx na xxxxxxx xxxxxxx xxxx xxxxxxxxx xxxx být xxxxx xxx 0,1&xxxx;% xxxxxxxxxxxx (xxxx.) xxxx nižší xxx xxxxxxxxxx koncentrační xxxxx xxxxxxxx xx XXX xxxxxxxxxx (karcinogenních, xxxxxxxxxxx x&xxxx;xxxxxxxxx xxx xxxxxxxxxx), xx-xx stanoven x&xxxx;xxxxxxx XX nařízení (XX) x.&xxxx;1272/2008 xxx xxxxxxxxxxxxx xxxxxxxxxx přísadu xx xxxxxx xxxxx xxx 0,1&xxxx;% hmotnostních (xxxx.), aby xxxx xxxxx xx považovat xx xxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, xxxxx není x&xxxx;xxxxxx xxxxxxxxxxx omezení xxxxxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxx jiný limit. |
(15) |
Opatření xxxxxxxxx tímto xxxxxxxxx xxxx x&xxxx;xxxxxxx xx xxxxxxxxxxx Xxxxxxx xxxxxx xxx rostliny, zvířata, xxxxxxxxx x&xxxx;xxxxxx, |
XXXXXXX XXXX XXXXXXXX:
Xxxxxx&xxxx;1
Xxxxxxx III nařízení (XX) č. 1107/2009 xx xxxx v souladu x&xxxx;xxxxxxxx xxxxxx xxxxxxxx.
Článek 2
Členské státy, xxxxx xxxxxxx xxxxxxxx xxx xxxxxxxxx xx xxxxxxx xxxxxxx xxxxxxxxxx formulační xxxxxxx xxxxxxx xx xxxxxxx x&xxxx;xxxxxxx XXX xxxxxxxx (ES) x.&xxxx;1107/2009, xx znění xxxxxx xxxxxxxx, xxxxxxx povolení xxxxx nebo odejmou xx xxxxxxxx, avšak xxxxxxxxxx xx 24.&xxxx;xxxxxx 2023.
Článek 3
Členské státy xxxxxxxx xxxxxxx xx xxx xxxx xxxxxxxxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxx na seznamu x&xxxx;xxxxxxx XXX xxxxxxxx (XX) č. 1107/2009, xx xxxxx xxxxxx nařízení.
Členské xxxxx, xxxxx povolily xxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxx uvedené na xxxxxxx v příloze XXX xxxxxxxx (ES) č. 1107/2009, xx xxxxx tohoto xxxxxxxx, xxxxxxx xxxxxxxx xxxxx nebo xxxxxxx xx xxxxxxxx, avšak xxxxxxxxxx xx 24.&xxxx;xxxxxx 2023.
Xxxxxx&xxxx;4
Xxxxxxxxx xxxxxxxx xxxxx xxxxxxx xxxxxxxxx xxxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;46 xxxxxxxx (XX) x.&xxxx;1107/2009 xxxx xxxxxxxxxxxxxx předpisy xxx xxxxxxxxxx xxxxxxxxx xxxx xxx xx xxxxxxxxx x&xxxx;xxxx xxxxxxxx xxx xxxxxx a distribuci xxxxxxxxxx xx tři měsíce x&xxxx;xxx xxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxx xx xxxxxxx xxxxx xxxxxx po xxxx xxxxx nebo xxxxxx xxxxxxxx uvedených x&xxxx;xxxxxxxx 2 a 3.
Článek 5
Toto nařízení xxxxxxxx x&xxxx;xxxxxxxx xxxxxxxx dnem xx xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxx Evropské xxxx.
Xxxx xxxxxxxx je xxxxxxx x&xxxx;xxxxx xxxxxxx x&xxxx;xxxxx xxxxxxxxxx xx xxxxx xxxxxxxxx xxxxxxx.
X&xxxx;Xxxxxxx xxx 3.&xxxx;xxxxxx 2021.
Za Xxxxxx
xxxxxxxxxxx
Xxxxxx XXX XXX XXXXX
(1)&xxxx;&xxxx;Xx. věst. X&xxxx;309, 24.11.2009, x.&xxxx;1.
(2)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 xx dne 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx látek x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx směrnic 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (XX) x.&xxxx;1907/2006 (Xx. xxxx. X&xxxx;353, 31.12.2008, x.&xxxx;1).
(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x.&xxxx;1907/2006 xx xxx 18.&xxxx;xxxxxxxx&xxxx;2006 o registraci, hodnocení, xxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxx xxxxx, x&xxxx;xxxxxxx Xxxxxxxx xxxxxxxx pro chemické xxxxx, x&xxxx;xxxxx směrnice 1999/45/XX a o zrušení xxxxxxxx Xxxx (XXX) x.&xxxx;793/93, xxxxxxxx Xxxxxx (ES) x.&xxxx;1488/94, směrnice Xxxx 76/769/XXX x&xxxx;xxxxxxx Xxxxxx 91/155/XXX, 93/67/XXX, 93/105/XX x&xxxx;2000/21/XX (Úř. věst. X&xxxx;396, 30.12.2006, x.&xxxx;1).
(4)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;528/2012 ze xxx 22.&xxxx;xxxxxx&xxxx;2012 x&xxxx;xxxxxxxx xxxxxxxxxx přípravků xx xxx a jejich používání (Xx. xxxx. X&xxxx;167, 27.6.2012, s. 1).
(5) Nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) 2019/1021 xx xxx 20.&xxxx;xxxxxx&xxxx;2019 x&xxxx;xxxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxx (Úř. xxxx. L 169, 25.6.2019, x.&xxxx;45).
(6)&xxxx;&xxxx;Xxxxxxxx Xxxx 91/414/EHS xx xxx 15.&xxxx;xxxxxxxx&xxxx;1991 x&xxxx;xxxxxxx přípravků xx xxxxxxx rostlin na xxx (Xx. věst. X&xxxx;230, 19.8.1991, s. 1).
(7) Prováděcí xxxxxxxx Xxxxxx (XX) 2016/1313 xx xxx 1.&xxxx;xxxxx&xxxx;2016, xxxxxx se xxxx xxxxxxxxx xxxxxxxx (XX) č. 540/2011, xxxxx xxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxxx xxxxx xxxxxxxxx (Xx. věst. L 208, 2.8.2016, x.&xxxx;1).
(8)&xxxx;&xxxx;Xxxxxxxxx xxxxxxxxxx Xxxxxx (XX) 2016/109 xx dne 27. ledna 2016 x&xxxx;xxxxxxxxxxx XXXX (1600; 1.8) xxxx stávající xxxxxx xxxxx xxx xxxxxxx v biocidních xxxxxxxxxxx xxxxxxxx xxx xxxx xxxxxxxxx 1, 6 x&xxxx;9 (Úř. xxxx. X&xxxx;21, 28.1.2016, x.&xxxx;84).
(9)&xxxx;&xxxx;Xxxxxxxxx xxxxxxxxxx Komise (EU) 2018/619 xx dne 20.&xxxx;xxxxx&xxxx;2018 x&xxxx;xxxxxxxxxxx XXXX (1415; 4.7) jako xxxxxxxxx účinné xxxxx xxx xxxxxxx x&xxxx;xxxxxxxxxx xxxxxxxxxxx xxxx 1, 5 x&xxxx;6 (Úř. xxxx. X&xxxx;102, 23.4.2018, x.&xxxx;21).
XXXXXXX
Xxxxxxx XXX xxxxxxxx (XX) x.&xxxx;1107/2009 xx xxxxxxxxx xxxxx:
„XXXXXXX III
Seznam xxxxxxxxxxxx přísad, xxxxx xxxx nepřijatelné xxxx xxxxxxx přípravků xx xxxxxxx xxxxxxx, xxxxxxx x&xxxx;xxxxxx&xxxx;27&xxxx;&xxxx;(1)
X. |
Xxxxx |
Xxxxx XX/xxxx xxxxx |
Xxxxx XXX |
Xxxxx XX |
Xxxxxxxxxxx/xxxx vlastnosti |
1. |
1-chlor-2,3-epoxypropan |
epichlorhydrin; 2,3-xxxxxxxxxxx-xxxxxxx |
106-89-8 |
203-439-8 |
xxxxxxxxxxxx xxx. 1X |
2. |
1,2-xxxxxxxxxxxx |
1,2-xxxxxxxxxxxx; xxxxx, 1,2-xxxxxxx- |
107-06-2 |
203-458-1 |
xxxxxxxxxxxx kat. 1B |
3. |
2-ethoxyethanol |
2-ethoxyethanol; ethanol, 2-xxxxxx- |
110-80-5 |
203-804-1 |
xxxxxxx xxx xxxxxxxxxx xxx. 1B |
4. |
2-ethoxyethyl-acetát |
2-ethoxyethanol-acetát; ethanol, 2-xxxxxx-, 1-acetát |
111-15-9 |
203-839-2 |
toxické xxx xxxxxxxxxx kat. 1X |
5. |
1-xxxxxxxxxxxxxxx-2-xx |
1-xxxxxxxxxxxxxxx-2-xx; X-xxxxx-2-xxxxxxxxxx |
2687-91-4 |
220-250-6 |
xxxxxxx xxx reprodukci xxx. 1X |
6. |
2-xxxxxxxxxxxxxx |
2-xxxxxxxxxxxxxx; xxxxxxx, 2-methoxy- |
109-86-4 |
203-713-7 |
toxické xxx xxxxxxxxxx kat. 1X |
7. |
2-xxxxxxxxxxxx-xxxxxx |
2-xxxxxxxxxxxx-xxxxxx; xxxxxxx, 2-xxxxxxx-, 1-acetát; 2-methoxyethanol-acetát |
110-49-6 |
203-772-9 |
toxické pro xxxxxxxxxx kat. 1X |
8. |
2-xxxxxxxxxxxxx-1-xx |
2-xxxxxxxxxxxxx-1-xx; 1-xxxxxxxx, 2-xxxxxxx- |
1589-47-5 |
216-455-5 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
9. |
1-xxxxxxxxxxxxxxxx-2-xx |
1-xxxxxx-2-xxxxxxxxxx; 2-xxxxxxxxxxxx, 1-xxxxxx- |
872-50-4 |
212-828-1 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
10. |
2-xxxxxxxxxxx |
2-xxxxxxxxxxx; xxxxxx, 2-xxxxx- |
79-46-9 |
201-209-1 |
xxxxxxxxxxxx xxx. 1X |
11. |
xxxxxxxxxx xxxx, ethoxylované |
alkylaminy xxxx, xxxxxxxxxxxx; xxxxxxxxxxxx amin xxxx |
61791-26-2 |
xxxxx xxxx chybějící xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx xxxxxx na xxxxxx xxxxxx xxxx xxxxxxx xxxxxxxxx |
|
12. |
xxxxxxxxxx loje, ethoxylované x&xxxx;xxxxxxxxxxxxx |
xxxxxxxxxx xxxx, ethoxylované x&xxxx;xxxxxxxxxxxxx; xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx xxxx xxxx |
68213-26-3 |
xxxxx xxxx xxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx xxxxxx xx xxxxxx xxxxxx xxxx xxxxxxx xxxxxxxxx |
|
13. |
xxxxxxxxx xxxxxx |
xxxxxxxxxxxx xxxxxx; xxxxxx, xxxxxxxxxxxx |
77536-66-4 |
xxxxxxxxxxxx kat. 1&xxxx;X |
|
14. |
xxxxxxxxx xxxxxx; xxxxxx, xxxxxxxxx |
12172-73-5 |
xxxxxxxxxxxx xxx. 1&xxxx;X |
||
15. |
xxxxxxxxxxxx xxxxxx; xxxxxx, xxxxxxxxxxxx |
77536-67-5 |
xxxxxxxxxxxx xxx. 1&xxxx;X |
||
16. |
xxxxxxxxxxxx xxxxxx; xxxxxx, xxxxxxxxxxxx |
12001-29-5 |
xxxxxxxxxxxx kat. 1 A |
||
17. |
krocidolitový xxxxxx; xxxxxx, xxxxxxxxxxxxx |
12001-28-4 |
xxxxxxxxxxxx xxx. 1&xxxx;X |
||
18. |
xxxxxxxxxxx xxxxxx; xxxxxx, xxxxxxxxxxx |
77536-68-6 |
xxxxxxxxxxxx xxx. 1 A |
||
19. |
benzen |
benzen |
71-43-2 |
200-753-7 |
karcinogenní xxx. 1&xxxx;X/ xxxxxxxxx xxx. 1B |
20. |
benzo[def]chrysen (2); benzo[pqr]tetrafen |
benzo[def]chrysen; benzo[a]pyren |
50-32-8 |
200-028-5 |
karcinogenní xxx. 1X/xxxxxxxxx xxx. 1X/ xxxxxxx xxx xxxxxxxxxx xxx. 1X |
21. |
xxx(2-xxxxxxxxxxxx)xxxxxx-1,2-xxxxxxxxxxxx |
xxxxxxxxxx-xxxxxx |
84-69-5 |
201-553-2 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxx zdraví), xxxxxxx xxx xxxxxxxxxx kat. 1X |
22. |
xxxxxxxx xxxxxx |
xxxxxxxx boritá |
10043-35-3 11113-50-1 |
233-139-2 234-343-4 |
toxické xxx reprodukci kat. 1X |
23. |
xxxxxxxxxxx xxxxxxx |
xxxxxxxxxxx disodný; xxxxxxxxxxx disodný, xxxxxxx |
12008-41-2 |
234-541-0 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
24. |
xxxxxxxxxxx disodný, xxxxxxxxxxx |
xxxxxxxx xxxxxx, xxxxxxx xxx, xxxxxxxxxxx |
12280-03-4 |
234-541-0 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
25. |
xxxxxxxxxxxx xxxxxxx, xxxxxxx |
xxxxxxxxxxxx disodný, bezvodý; borum-natrium-oxid |
1330-43-4 |
215-540-4 |
toxické xxx reprodukci kat. 1X |
26. |
xxxxxxxxxxxx xxxxxxx, dekahydrát |
borax |
1303-96-4 |
215-540-4 |
toxické xxx xxxxxxxxxx xxx. 1X |
27. |
xxxxxxxxxxxx disodný, pentahydrát |
borum-natrium-oxid, xxxxxxxxxxx |
12179-04-3 |
215-540-4 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
28. |
xxxxxxxx orthoboritá, xxxxx xxx |
xxxxxxxx xxxxxxxxxxx, xxxxx xxx; xxxxxxxx xxxxxx, sodná xxx |
13840-56-7 |
237-560-2 |
xxxxxxx xxx reprodukci kat. 1X |
29. |
xxxxxxxxxxxx xxxxxxx, monohydrát |
tetraboritan xxxxxxx, xxxxxxxxxx; xxxxx-xxxxxxx-xxxx, xxxxxxxxxx |
12267-73-1 |
235-541-3 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
30. |
xxxx-1,3-xxxx |
xxxx-1,3-xxxx; 1,3-xxxxxxxx |
106-99-0 |
203-450-8 |
xxxxxxxxxxxx xxx. 1 A/ mutagenní xxx. 1X |
31. |
xxxxx xxxxxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxxxx (x.&xxxx;XX 203-450-8) |
xxxxx |
106-97-8 |
203-448-7 |
xxxxxxxxxxxx xxx. 1 A |
32. |
copoly(bisiminoimidokarbonyl, xxxxxxxxxxxx-xxxxxxxxxxxx), (xxxxxxxxxxxxxxxxxx, hexamethylen-hydrochlorid) |
guanidin, X,X“’-1,6-xxxxxxxxxxxx[X’-xxxxx-, xxxxxxx x&xxxx;1,6-xxxxxxxxxxxxx, xxxxxxxxxxxx; xxxx[xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx-1,6-xxxxxxxxx], xxxxxxxxxxxx; xxxxxxxx, X-xxxxx-, slouč. x&xxxx;1,6-xxxxxxxxxxxxx (2:1), xxxxxxx x&xxxx;1,6-xxxxxxxxxxxxx, xxxxxxxxxxxx (1:2); XXXX |
27083-27-8 x 32289-58-0 x 1802181-67-4 |
xxxxxxxxxxx xxx xxxxxxx x&xxxx;xxxxxxxxxx xxxxxxxxxxx xxxx 6 (xxxxxxxxxxx xxx výrobky x&xxxx;xxxxxxxxxx xxxxxxx) |
|
33. |
xxxxxxx-xxxxxx |
x-xxxxx-xxxxxx; xxxxxxx-xxxxxx-1,2-xxxxxxxxxxxx |
84-74-2 |
201-557-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxx zdraví), toxické xxx xxxxxxxxxx xxx. 1X |
34. |
xxxxxxxxx (ropné), xxxxxxxxxxxxx xxxxx xxxxxxxxxx x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx do dimethylsulfoxidu (XXXX) (xxxxxxxxx xxxxxxxx XX 346) |
64742-52-5 |
265-155-0 |
xxxxxxxxxxxx kat. 1X |
|
35. |
xxxxxxxxx (xxxxx), xxxxxxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346) |
64742-54-7 |
265-157-1 |
xxxxxxxxxxxx xxx. 1X |
|
36. |
xxxxxxxxx (xxxxx), hydrogenované xxxxx xxxxxxxxxx x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% hmotnostních xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (stanovení postupem XX 346) |
64742-53-6 |
265-156-6 |
xxxxxxxxxxxx xxx. 1X |
|
37. |
xxxxxxxxx (xxxxx), hydrogenované xxxxx parafinické x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx látek xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346) |
64742-55-8 |
265-158-7 |
xxxxxxxxxxxx kat. 1X |
|
38. |
xxxxxxxxx (xxxxx), xxxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx parafinické x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% hmotnostních xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (DMSO) (xxxxxxxxx xxxxxxxx XX 346) |
64742-65-0 |
265-169-7 |
xxxxxxxxxxxx xxx. 1X |
|
39. |
xxxxxxxxx (xxxxx), xxxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx látek extrahovatelných xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346) |
64741-88-4 |
265-090-8 |
xxxxxxxxxxxx kat. 1X |
|
40. |
xxxxxxxxx (xxxxx), rozpouštědlově xxxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx xx dimethylsulfoxidu (XXXX) (stanovení postupem XX 346) |
64741-89-5 |
265-091-3 |
xxxxxxxxxxxx kat. 1X |
|
41. |
xxxxxxxxxxx |
xxxxxxxxxxx; oxiran; epoxyethan |
75-21-8 |
200-849-9 |
karcinogenní xxx. 1B/ mutagenní kat. 1X |
42. |
xxxxxxxxxxx |
xxxxxxxxxxx; xxxxxxxx; xxxxxxxx; xxxxxx |
50-00-0 |
200-001-8 |
xxxxxxxxxxxx xxx. 1B |
43. |
formamid |
formamid; xxxxxxxxxx |
75-12-7 |
200-842-0 |
xxxxxxx xxx xxxxxxxxxx xxx. 1B |
44. |
isobutan (xxxxxxxxxx ≥&xxxx;0,1&xxxx;% butadienu (č. ES 203-450-8)) |
xxxxxxxx; propan, 2-xxxxxx- |
75-28-5 |
200-857-2 |
xxxxxxxxxxxx xxx. 1&xxxx;X/ xxxxxxxxx kat. 1X |
45. |
xxxxxx xxxxx (xxxxx), X20–50, xxxxxxxxxxxxx neutrální xxxxx, vysokoviskozní s obsahem ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx xxxxxxxxxxxxxxxx xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346) |
72623-85-9 |
276-736-3 |
karcinogenní kat. 1X |
|
46. |
xxxxxx oleje (ropné), X15–30, hydrogenované xxxxxxxxx xxxxx, x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx látek xxxxxxxxxxxxxxxx xx dimethylsulfoxidu (DMSO) (xxxxxxxxx xxxxxxxx IP 346) |
72623-86-0 |
276-737-9 |
xxxxxxxxxxxx xxx. 1B |
|
47. |
mazací xxxxx (xxxxx), X20–50, xxxxxxxxxxxxx xxxxxxxxx xxxxx, x&xxxx;xxxxxxx ≥ 3,0 % xxxxxxxxxxxx xxxxx extrahovatelných xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx XX 346) |
72623-87-1 |
276-738-4 |
xxxxxxxxxxxx xxx. 1X |
|
48. |
xxxxxx xxxxx (xxxxx), X17–32, rozpouštědlově xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxxxx, x&xxxx;xxxxxxx ≥&xxxx;3,0&xxxx;% xxxxxxxxxxxx xxxxx extrahovatelných xx xxxxxxxxxxxxxxxxx (XXXX) (xxxxxxxxx xxxxxxxx IP 346) |
101316-70-5 |
309-875-6 |
xxxxxxxxxxxx xxx. 1X |
|
49. |
xxxxxxxxx xxxxxx (xxxxx), xxxxx alkylát, xxxxxxxx xxxxxxxxxx xxxxxxx X9–X12, x&xxxx;xxxxxxx ≥ 0,1 % xxxxxxx (č. ES 200-753-7) |
64741-65-7 |
265-067-2 |
xxxxxxxxxxxx xxx. 1X/ xxxxxxxxx xxx. 1X |
|
50. |
xxxxxxxxx xxxxxx (xxxxx), xxxxxxxxxxxx odsířená těžká, xxxxxxxx X7–X12, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% benzenu (x.&xxxx;XX 200-753-7) |
64742-82-1 |
265-185-4 |
xxxxxxxxxxxx xxx. 1&xxxx;X/ xxxxxxxxx xxx. 1X |
|
51. |
xxxxxxxxx frakce (xxxxx), xxxxxxxxxxxx xxxxxxxx xxxxx, dearomatizovaná, převážně x&xxxx;xxxxxxxx x&xxxx;xxxxxxxxxxxxx C7, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7) |
92045-53-9 |
295-434-2 |
xxxxxxxxxxxx kat. 1&xxxx;X/ xxxxxxxxx xxx. 1X |
|
52. |
xxxxxxxxx xxxxxx (xxxxx), xxxxxxxxxxxxx xxxxx, převážně X6–X13, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% benzenu (x.&xxxx;XX 200-753-7) |
64742-48-9 |
265-150-3 |
xxxxxxxxxxxx kat. 1&xxxx;X/ xxxxxxxxx xxx. 1B |
|
53. |
benzínová xxxxxx (xxxxx), xxxxx xxxxxxxxxx, xxxxxxxx X8–X10, x&xxxx;xxxxxxx ≥&xxxx;0,1&xxxx;% xxxxxxx (x.&xxxx;XX 200-753-7) |
64742-95-6 |
265-199-0 |
karcinogenní xxx. 1&xxxx;X/ xxxxxxxxx xxx. 1X |
|
54. |
xxxxxxxxxxx |
xxxxxxxxxxx; xxxxxx, xxxxx- |
98-95-3 |
202-716-0 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
55. |
X-xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxx; xxxxxxxx, X-xxxxxx- |
123-39-7 |
204-624-6 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
56. |
xxxxxxxxxxx: xxxxx x&xxxx;xxxxxxxxx x/xxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx s počtem 9 xxxxxx kovalentně xxxxxxxx x&xxxx;xxxxxxx na xxxxxxxxx xxxxxx, zahrnující xxxxxx xxxxx, které xxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxxxx |
4-(3,5-xxxxxxxxxxxxxx-3-xx)xxxxx; xxxxx, 4-(1-xxxxx-1,3-xxxxxxxxxxxxxx)-; 4-(1-xxxxx-1,3-xxxxxxxxxxxxxx)xxxxx |
186825-36-5 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx) |
|
57. |
4-(3,6-xxxxxxxxxxxxxx-3-xx)xxxxx; xxxxx, 4-(1-xxxxx-1,4-xxxxxxxxxxxxxx)-; 4-(1-xxxxx-1,4-xxxxxxxxxxxxxx)xxxxx |
142731-63-3 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx prostředí) |
||
58. |
4-(2-methyloktan-2-yl)fenol; p-(1,1-dimethylheptyl)fenol; fenol, 4-(1,1-xxxxxxxxxxxxxx)- |
30784-30-6 |
250-339-5 |
xxxxxxxxxx xxxxxxxxxxxx narušení endokrinní xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
59. |
4-(3-xxxxxxxxxxx-3-xx)xxxxx; xxxxx, 4-(1-xxxxx-1-xxxxxxxxxxx)-; 4-(1-xxxxx-1-xxxxxxxxxxx)xxxxx |
52427-13-1 |
257-907-1 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx činnosti (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
60. |
4-xxxxxxxxxx x-xxxxxxxxxx; xxxxx, 4-nonyl- |
104-40-5 |
203-199-4 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
61. |
xxxxxxxxxxxxx |
11066-49-2 |
234-284-4 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
62. |
x-xxxxxxxxxxxxx; xxxxx, 4-xxxxxxxx- |
26543-97-5 |
247-770-6 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
63. |
xxxxxxxxxx; xxxxx, xxxxx- |
25154-52-3 |
246-672-0 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx činnosti (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
64. |
xxxxx, 4-(1-xxxxxxxxxxx)-; x-(1-xxxxxxxxxxx)xxxxx |
17404-66-9 |
241-427-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
65. |
xxxxx, 4-xxxxx-, xxxxxxxxxx |
84852-15-3 |
284-325-5 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
66. |
xxxxx, xxxxx-, rozvětvený |
90481-04-2 |
291-844-0 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 písm. x) xxxxxxxx REACH – xxxxxxx prostředí) |
|
67. |
nonylfenoly, xxxxxxxxxxxx: xxxxx x&xxxx;xxxxxxxxx x/xxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx x&xxxx;xxxxxx 9 xxxxxx xxxxxxxxxx xxxxxxxx s fenolem xx xxxxxxxxx pozici, xxxxxxxxxxxx, xxxxxxxxxx rovněž xxxxx, které xxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxx xxxx xxxxxx kombinaci |
nonylfenol, xxxxxxxxxxxx; xxxx(xxx-1,2-xxxxxxxxx), α-(nonylfenyl)-ω-hydroxy- |
500-024-6 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
68. |
4-xxxxxxxxxx, rozvětvený, xxxxxxxxxxxx, 1–2,5 xxx; xxxx(xxx-1,2-xxxxxxxxx), α-(4-xxxxxxxxxx)-ω-xxxxxxx-, rozvětvený |
500-315-8 |
vlastnosti vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
69. |
4-xxxxxxxxxx, xxxxxxxxxxxx, 1–2,5 xxx |
500-045-0 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx prostředí) |
||
70. |
2-(2-{2-[2-(4-nonylfenoxy)ethoxy]ethoxy}ethoxy)ethan-1-ol; 2-[2-[2-[2-(4-nonylfenoxy)ethoxy]ethoxy]ethoxy]ethanol; ethanol, 2-[2-[2-[2-(4-nonylfenoxy)ethoxy]ethoxy]ethoxy]- |
7311-27-5 |
230-770-5 |
vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
|
71. |
2-[2-(4-nonylfenoxy)ethoxy]ethanol; ethanol, 2-[2-(4-xxxxxxxxxxx)xxxxxx]- |
20427-84-3 |
243-816-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
72. |
20-(4-xxxxxxxxxxx)-3,6,9,12,15,18-xxxxxxxxxxxxx-1-xx; 3,6,9,12,15,18-xxxxxxxxxxxxxx-1-xx, 20-(4-nonylfenoxy)- |
27942-27-4 |
248-743-1 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx REACH – xxxxxxx prostředí) |
|
73. |
2-[2-[2-[2-(4-nonylfenoxy)ethoxy]ethoxy]ethoxy]ethan-1-ol; ethanol, 2-[2-[2-[2-(4-nonylfenoxy)ethoxy]ethoxy]ethoxy]- |
7311-27-5 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx) |
||
74. |
26-(4-xxxxxxxxxxx)-3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx; 3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx, 26-(4-xxxxxxxxxxx)- |
14409-72-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
75. |
17-(4-xxxxxxxxxxx)-3,6,9,12,15-xxxxxxxxxxxxxxxxxx-1-xx; 3,6,9,12,15-xxxxxxxxxxxxxxxxxx-1-xx, 17-(4-xxxxxxxxxxx)- |
34166-38-6 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx prostředí) |
||
76. |
poly(oxy-1,2-ethandiyl), α-(4-xxxxxxxxxx)-ω-xxxxxxx-, xxxxxxxxxx |
127087-87-0 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
77. |
xxxx(xxx-1,2-xxxxxxxxx), α-(4-xxxxxxxxxx)-ω-xxxxxxx- |
26027-38-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
78. |
ethanol, 2-(4-xxxxxxxxxxx)- |
104-35-8 |
xxxxxxxxxx xxxxxxxxxxxx narušení endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení REACH – životní xxxxxxxxx) |
||
79. |
xxxxxxxxxxxxx, xxxxxxxxxxxx; xxxx(xxx-1,2-xxxxxxxxx), α-(xxxxxxxxxxxxx)-ω-xxxxxxx- |
37205-87-1 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
80. |
2-[2-(4-terc-nonylfenoxy)ethoxy]ethanol; ethanol, 2-[2-(4-xxxx-xxxxxxxxxxx)xxxxxx]- |
156609-10-8 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
81. |
xxxx(xxx-1,2-xxxxxxxxx), α-(xxxxxxxxxx)-ω-xxxxxxx- xxxxxxxxxx, ethoxylovaný |
9016-45-9 |
vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx REACH – xxxxxxx prostředí) |
||
82. |
oktylfenoly: látky s lineárním x/xxxx rozvětveným xxxxxxxxx xxxxxxxx x&xxxx;xxxxxx 8 xxxxxx xxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxx xx jakékoliv xxxxxx, xxxxxxxxxx xxxxxx xxxxx, které xxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxxxx |
x-xxxxxxxxxx; 4-xxxxxxxxxx |
1806-26-4 |
217-302-5 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
83. |
4-(2,4,4-xxxxxxxxxxxxxxx-2-xx)xxxxx; 4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx; 4-(xxxx-xxxxx)xxxxx; xxxxx, 4-(1,1,3,3-xxxxxxxxxxxxxxxx)-; 4-xxxx-xxxxxxxxxx |
140-66-9 |
205-426-2 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
84. |
xxxxxxxxxx; xxxxx, xxxxx- |
67554-50-1 |
266-717-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
85. |
xxxxx, 2-isooktyl- |
86378-08-7 |
vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
86. |
xxxxx, xxxxxxxx-; xxxxxxxxxxxxx |
11081-15-5 |
234-304-1 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx) |
|
87. |
xxxxx, 2-oktyl-; o-oktylfenol |
949-13-3 |
213-437-9 |
vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
88. |
xxxxx, 2-xxx-xxxxx-; x-xxx-xxxxxxxxxx |
26401-75-2 |
247-663-4 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
89. |
xxxxx, 4-xxxxxxxx-; x-xxxxxxxxxxxxx |
27013-89-4 |
248-164-4 |
xxxxxxxxxx vyvolávající narušení xxxxxxxxxx činnosti (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
90. |
xxxxx, 4-sek-oktyl-; p-sek-oktylfenol |
27214-47-7 |
248-330-6 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
91. |
xxxxx, xxx-xxxxx-; xxx-xxxxxxxxxx |
93891-78-2 |
299-461-0 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) nařízení XXXXX – životní prostředí) |
|
92. |
fenol, 4-(1-xxxxxxxxxx)-; x-(1-xxxxxxxxxx)xxxxx |
3307-00-4 |
221-989-7 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx) |
|
93. |
xxxxx, 2-(1-xxxxxxxxxxxxxx)-; x-(1-xxxxxxxxxxxx)xxxxx |
18626-98-7 |
242-459-1 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
94. |
xxxxx, 2-(1-xxxxxxxxxx)-; x-(1-xxxxxxxxxx)xxxxx |
17404-44-3 |
241-426-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
95. |
xxxxx, 2-(1-xxxxxxxxxxxx)-; x-(1-xxxxxxxxxxxx)xxxxx |
37631-10-0 |
253-574-1 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. f) nařízení XXXXX – životní xxxxxxxxx) |
|
96. |
xxxxx, 4-(1-xxxxxxxxxxxx)-; x-(1-xxxxxxxxxxxx)xxxxx |
3307-01-5 |
221-990-2 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. f) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
97. |
xxxxx, 2-(1-xxxxxxxxxxxx)-; x-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx |
3884-95-5 |
223-420-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
98. |
xxxxx, (1,1,3,3-xxxxxxxxxxxxxxxx)-; (1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx |
27193-28-8 |
248-310-7 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
99. |
xxxxx, (1-xxxxxxxxxxxx)-; (1-xxxxxxxxxxxx)xxxxx |
27985-70-2 |
248-759-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx prostředí) |
|
100. |
fenol, 4-(2-xxxxxxxxxxxx)- |
898546-19-5 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) nařízení REACH – xxxxxxx prostředí) |
||
101. |
fenol, 2-(2-xxxxxxxxxx)- |
28752-62-7 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
102. |
xxxxx, 4-(1-methylheptyl)-; p-(1-methylheptyl)fenol |
1818-08-2 |
217-332-9 |
vlastnosti xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
|
103. |
xxxxx, 4-(2-ethylhexyl)- |
69468-20-8 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
104. |
xxxxx, 4-(5-xxxxxxxxxxxx)- |
1824164-95-5 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
105. |
xxxxx, 2-(2-methylheptyl)- |
898546-20-8 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
||
106. |
xxxxx, 4-(2-xxxxxxxxxxxx)- |
119747-99-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx) |
||
107. |
xxxxx, 3-xxxxx- |
20056-69-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
108. |
xxxxx, 2-(1,1-xxxxxxxxxxxxx)- |
1824575-79-2 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx xxxxxxxxx) |
||
109. |
xxxxx, 4-(1,1-xxxxxxxxxxxxx)- |
30784-29-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
110. |
xxxxx, 4-(5,5-xxxxxxxxxxxxx)- |
13330-52-4 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx) |
||
111. |
xxxxx, 2-(5,5-dimethylhexyl)- |
1822989-97-8 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
112. |
xxxxx, 3-(1,1-dimethylhexyl)- |
70435-92-6 |
vlastnosti xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx) |
||
113. |
xxxxx, 4-(1,4-xxxxxxxxxxxxx)- |
164219-26-5 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) nařízení XXXXX – životní xxxxxxxxx) |
||
114. |
xxxxxxxxxxx, xxxxxxxxxxxx: xxxxx s lineárním x/xxxx rozvětveným xxxxxxxxx xxxxxxxx s počtem 8 xxxxxx kovalentně xxxxxxxx x&xxxx;xxxxxxx na jakékoliv xxxxxx, xxxxxxxxxxxx, xxxxxxxxxx xxxxxx xxxxx, xxxxx xxxxxxxx jakýkoliv x&xxxx;xxxxxxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxxxx |
xxxx(xxx-1,2-xxxxxxxxx), α-[(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx]-ω-xxxxxxx-; 2-(2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]xxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
9036-19-5 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
115. |
2-[4-(2,4,4-xxxxxxxxxxxxxxx-2-xx)xxxxxx]xxxxxxx; xxxx(xxx-1,2-xxxxxxxxx), α-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxx]-ω-xxxxxxx-; xxxxxxxxxx, xxxxxxxxxxxx |
9002-93-1 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
116. |
20-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]-3,6,9,12,15,18-xxxxxxxxxxxxx-1-xx; 3,6,9,12,15,18-xxxxxxxxxxxxxx-1-xx, 20-[4-(1,1,3,3-tetramethylbutyl)fenoxy]- |
2497-59-8 |
219-682-8 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
117. |
xxxxxxx, 2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
2315-67-5 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
118. |
ethanol, 2-[2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]xxxxxx]- |
2315-61-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – životní xxxxxxxxx) |
||
119. |
3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx, 26-(4-oktylfenoxy)- |
42173-90-0 |
255-695-5 |
vlastnosti vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
120. |
xxxx(xxx-1,2-xxxxxxxxx), α-(oktylfenyl)-ω-hydroxy-, xxxxxxxxxx |
68987-90-6 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
121. |
xxxx(xxx-1,2-xxxxxxxxx), α-[4-(6-xxxxxxxxxxxx)xxxxx]-ω-xxxxxxx- |
59379-12-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
122. |
ethanol, 2-(4-xxxxxxxxxxx)-; 2-(x-xxxxxxxxxxx)xxxxxxx |
51437-89-9 |
257-203-4 |
xxxxxxxxxx xxxxxxxxxxxx narušení endokrinní xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx REACH – xxxxxxx prostředí) |
|
123. |
poly(oxy-1,2-ethandiyl), α-(4-xxxxxxxxxx)-ω-xxxxxxx- |
26636-32-8 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
124. |
xxxx(xxx-1,2-xxxxxxxxx), α-[4-(1-xxxxxxxxxxxx)xxxxx]-ω-xxxxxxx- |
73935-42-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
125. |
3,6,9,12,15,18-hexaoxaeikosan-1-ol, 20-(4-xxxxxxxxxxx)-; 20-(4-xxxxxxxxxxx)-3,6,9,12,15,18-xxxxxxxxxxxxx-1-xx |
32742-88-4 |
251-190-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 písm. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
|
126. |
xxxxxxx, 2-[2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]-; 2-(x-xxxxxxxxxxx)xxxxxxx |
51437-92-4 |
xxxxxxxxxx vyvolávající narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
127. |
xxxxxxx, 2-[2-(4-oktylfenoxy)ethoxy]- |
51437-90-2 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
128. |
3,6,9,12,15-pentaoxaheptadekan-1-ol, 17-(4-xxxxxxxxxxx)- |
51437-94-6 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
129. |
xxxx(xxx-1,2-xxxxxxxxx), α-(xxxxxxxxxxxxx)-ω-xxxxxxx- |
9004-87-9 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
130. |
2-[2-[2-(4-xxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxxx |
51437-91-3 |
xxxxxxxxxx vyvolávající narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
131. |
3,6,9,12,15-xxxxxxxxxxxxxxxxxx-1-xx, 17-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
2497-58-7 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx endokrinní xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – xxxxxxx prostředí) |
||
132. |
ethanol, 2-[2-[2-[4-(1,1,3,3-tetramethylbutyl)fenoxy]ethoxy]ethoxy]- |
2315-62-0 |
vlastnosti xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) xxxxxxxx REACH – životní xxxxxxxxx) |
||
133. |
xxxxxxx, 2-[2-[2-[2-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]xxxxxx]xxxxxx]xxxxxx]- |
2315-63-1 |
xxxxxxxxxx vyvolávající xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) xxxxxxxx XXXXX – životní xxxxxxxxx) |
||
134. |
3,6,9,12-xxxxxxxxxxxxxxxxxx-1-xx, 14-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
2315-64-2 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
135. |
3,6,9,12,15,18,21,24-xxxxxxxxxxxxxxxx-1-xx, 26-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
2315-65-3 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (čl. 57 xxxx. x) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
136. |
3,6,9,12,15,18,21,24,27-xxxxxxxxxxxxxxxx-1-xx, 29-[4-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
2315-66-4 |
xxxxxxxxxx xxxxxxxxxxxx narušení xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. f) nařízení XXXXX – xxxxxxx xxxxxxxxx) |
||
137. |
xxxxxxx, 2-[3-(1,1,3,3-tetramethylbutyl)fenoxy]- |
1026254-24-9 |
vlastnosti xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx činnosti (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
138. |
xxxxxxx, 2-[2-(1,1,3,3-xxxxxxxxxxxxxxxx)xxxxxx]- |
84658-53-7 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx REACH – xxxxxxx prostředí) |
||
139. |
ethanol, 2-[2-(xxxxxxxxxxx)xxxxxx]- |
27176-92-7 |
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx (xx.&xxxx;57 xxxx. x) xxxxxxxx XXXXX – xxxxxxx xxxxxxxxx) |
||
140. |
X,X-xxxxxxxxxxxxxxxx |
X,X-xxxxxxxxxxxxxxxx; dimethylformamid; XXX |
68-12-2 |
200-679-5 |
xxxxxxx xxx xxxxxxxxxx kat. 1X |
141. |
xxxx-2-xxxxxx |
xxxxxxxxx; 2-xxxxxxxxxx |
79-06-1 |
201-173-7 |
xxxxxxxxxxxx kat. 1X/ xxxxxxxxx xxx. 1X |
142. |
xxxxxxx, xxxxxxxxxxxxx, x&xxxx;xxxxxxx ≥ 0,1 % xxxxxxx (x.&xxxx;XX 200-753-7) |
68391-11-7 |
269-929-9 |
xxxxxxxxxxxx xxx. 1&xxxx;X/ xxxxxxxxx xxx. 1X |
|
143. |
xxxxxxxx |
xxxxxxxx |
91-22-5 |
202-051-6 |
xxxxxxxxxxxx xxx. 1B |
144. |
tetrahydrofurfurylalkohol |
tetrahydrofurfurylalkohol; 2-furanmethanol, xxxxxxxxxx- |
97-99-4 |
202-625-6 |
xxxxxxx xxx xxxxxxxxxx xxx. 1X |
(1)&xxxx;&xxxx;Xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxxxx x&xxxx;xxxxxxx jako xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxx 0,1&xxxx;% (xxxxxxxxxxxx (xxxx.)), xxxx-xx x&xxxx;xxxx xxxxxxx uvedeno xxxxx.
(2)&xxxx;&xxxx;Xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxx xxxxx xxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxx 0,01&xxxx;% (hmotnostních (hmot.)), xxx xxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx xxxxxxxxxxx x&xxxx;xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008.